These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 36635309)

  • 21. Genotypic analysis of isoniazid and rifampin resistance in drug-resistant clinical Mycobacterium tuberculosis complex isolates in southern Turkey.
    Aslan G; Tezcan S; Serin MS; Emekdas G
    Jpn J Infect Dis; 2008 Jul; 61(4):255-60. PubMed ID: 18653964
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Molecular characterization of multidrug-resistant Mycobacterium tuberculosis isolated from south-central in China.
    Yu XL; Wen ZL; Chen GZ; Li R; Ding BB; Yao YF; Li Y; Wu H; Guo XK; Wang HH; Zhang SL
    J Antibiot (Tokyo); 2014 Apr; 67(4):291-7. PubMed ID: 24326341
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genetic mechanisms of co-emergence of INH-resistant
    Tafess K; Ng TT-L; Tam KK-G; Leung KS-S; Leung JS-L; Lee L-K; Lao HY; Chan CT-M; Yam W-C; Wong SSY; Lau TC-K; Siu GK-H
    Microbiol Spectr; 2024 Apr; 12(4):e0213323. PubMed ID: 38466098
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Detection of genomic mutations in katG, inhA and rpoB genes of Mycobacterium tuberculosis isolates using polymerase chain reaction and multiplex allele-specific polymerase chain reaction.
    Khosravi AD; Goodarzi H; Alavi SM
    Braz J Infect Dis; 2012; 16(1):57-62. PubMed ID: 22358357
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The occurrence and frequency of genomic mutations that mediate Isoniazid and Rifampicin resistance in
    Kumwenda GP; Chipungu G; Sloan DJ; Kaimila Y; Chiumya K; Pangani H
    Malawi Med J; 2018 Mar; 30(1):1-5. PubMed ID: 29868151
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Profiling and identification of novel rpoB mutations in rifampicin-resistant Mycobacterium tuberculosis clinical isolates from Pakistan.
    Qadir M; Tahseen S; McHugh TD; Hussain A; Masood F; Ahmed N; Faryal R
    J Infect Chemother; 2021 Nov; 27(11):1578-1583. PubMed ID: 34244055
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prevalence of katG Ser315 substitution and rpoB mutations in isoniazid-resistant Mycobacterium tuberculosis isolates from Brazil.
    Höfling CC; Pavan EM; Giampaglia CM; Ferrazoli L; Aily DC; de Albuquerque DM; Ramos MC
    Int J Tuberc Lung Dis; 2005 Jan; 9(1):87-93. PubMed ID: 15675556
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Molecular characteristics of rifampin and isoniazid resistant Mycobacterium tuberculosis strains from Beijing, China.
    Jiao WW; Mokrousov I; Sun GZ; Li M; Liu JW; Narvskaya O; Shen AD
    Chin Med J (Engl); 2007 May; 120(9):814-9. PubMed ID: 17531124
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Whole Genome Sequencing Investigation of a Tuberculosis Outbreak in Port-au-Prince, Haiti Caused by a Strain with a "Low-Level" rpoB Mutation L511P - Insights into a Mechanism of Resistance Escalation.
    Ocheretina O; Shen L; Escuyer VE; Mabou MM; Royal-Mardi G; Collins SE; Pape JW; Fitzgerald DW
    PLoS One; 2015; 10(6):e0129207. PubMed ID: 26039194
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Molecular characteristics of rifampin- and isoniazid-resistant mycobacterium tuberculosis strains isolated in Vietnam.
    Minh NN; Van Bac N; Son NT; Lien VT; Ha CH; Cuong NH; Mai CT; Le TH
    J Clin Microbiol; 2012 Mar; 50(3):598-601. PubMed ID: 22170905
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Direct detection of Mycobacterium tuberculosis and drug resistance in respiratory specimen using Abbott Realtime MTB detection and RIF/INH resistance assay.
    Tam KK; Leung KS; To SW; Siu GK; Lau TC; Shek VC; Tse CW; Wong SS; Ho PL; Yam WC
    Diagn Microbiol Infect Dis; 2017 Oct; 89(2):118-124. PubMed ID: 28780247
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genome sequencing of Mycobacterium tuberculosis clinical isolates revealed isoniazid resistance mechanisms undetected by conventional molecular methods.
    Laurent S; Zakham F; Bertelli C; Merz L; Nicod L; Mazza-Stalder J; Greub G; Jaton K; Opota O
    Int J Antimicrob Agents; 2020 Aug; 56(2):106068. PubMed ID: 32603684
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Molecular characterization of drug-resistant Mycobacterium tuberculosis isolates in Guangdong, China.
    Wang YC; Zhu RY; Xu YY; Zhao MQ; Liu YH; Li B; Chen JD
    Jpn J Infect Dis; 2009 Jul; 62(4):270-4. PubMed ID: 19628903
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Molecular Characterization of Mutations in Isoniazid- and Rifampicin-Resistant Mycobacterium tuberculosis Isolated in Thailand.
    Rudeeaneksin J; Phetsuksiri B; Nakajima C; Fukushima Y; Suthachai W; Tipkrua N; Suthum K; Jekloh N; Bunchoo S; Srisungngam S; Klayut W; Hamada S; Suzuki Y
    Jpn J Infect Dis; 2023 Jan; 76(1):39-45. PubMed ID: 36047179
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Detection and characterization of mutations in genes related to isoniazid resistance in Mycobacterium tuberculosis clinical isolates from Iran.
    Bakhtiyariniya P; Khosravi AD; Hashemzadeh M; Savari M
    Mol Biol Rep; 2022 Jul; 49(7):6135-6143. PubMed ID: 35366177
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Occurrence of diverse mutations in isoniazid- and rifampicin-resistant Mycobacterium tuberculosis isolates from autochthonous and immigrant populations of Saudi Arabia.
    Varghese B; Shoukri M; Memish Z; Abuljadayel N; Alhakeem R; Alrabiah F; Al-Hajoj S
    Microb Drug Resist; 2014 Dec; 20(6):623-31. PubMed ID: 25014484
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of a Molecular Test for Detection of Mycobacterium tuberculosis Isolates Resistant to Rifampicin and Isoniazid.
    Benaissa E; Benlahlou Y; Bssaibis F; Maleb A; Elouennass M
    Clin Lab; 2022 Mar; 68(3):. PubMed ID: 35254025
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Significance of Coexisting Mutations on Determination of the Degree of Isoniazid Resistance in Mycobacterium tuberculosis Strains.
    Karunaratne GHRE; Wijesundera SS; Vidanagama D; Adikaram CP; Perera J
    Microb Drug Resist; 2018; 24(6):844-851. PubMed ID: 29683767
    [TBL] [Abstract][Full Text] [Related]  

  • 39. New insight into the molecular characterization of isoniazid and rifampicin resistant Mycobacterium tuberculosis strains from Saudi Arabia.
    Varghese B; Hillemann A; Wijayanti DR; Shoukri M; Al-rabiah F; Al-Omari R; Al-Hajoj S
    Infect Genet Evol; 2012 Apr; 12(3):549-56. PubMed ID: 22326932
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Systematic Review of Mutations Associated with Isoniazid Resistance Points to Continuing Evolution and Subsequent Evasion of Molecular Detection, and Potential for Emergence of Multidrug Resistance in Clinical Strains of Mycobacterium tuberculosis.
    Valafar SJ
    Antimicrob Agents Chemother; 2021 Feb; 65(3):. PubMed ID: 33361298
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.